Search / Trial NCT06225583

Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

Launched by THE CLEVELAND CLINIC · Jan 17, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Lower Back Pain Cohort
  • * Positive diagnosis of sacroiliac pain or lumbosacral facet arthritis pain
  • * Age ≥ 18 years
  • Bertolotti's Syndrome Cohort
  • * Positive diagnosis of Bertolotti's Syndrome
  • * Age ≥ 18 years
  • * Positive imaging for Bertolotti's Syndrome
  • * Previous analgesic injection results
  • Exclusion Criteria:
  • Lower Back Pain Cohort
  • * History of spinal deformity, previous spinal surgeries, spinal infections
  • * Pregnant women
  • Bertolotti's Syndrome Cohort
  • * History of spinal deformity, previous spinal surgeries, spinal infections
  • * Pregnant women

About The Cleveland Clinic

The Cleveland Clinic is a renowned nonprofit academic medical center based in Cleveland, Ohio, recognized for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, the Cleveland Clinic leverages its multidisciplinary expertise and state-of-the-art facilities to conduct groundbreaking studies aimed at improving patient outcomes across a wide range of medical conditions. With a strong emphasis on patient-centered care, the institution fosters collaboration among researchers, clinicians, and patients to explore new treatments and therapies, contributing significantly to the global body of medical knowledge.

Locations

Cleveland, Ohio, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0